Clinical Trials Browser

Bacterial Infections, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Cross Infection, Infections, Urinary Tract Infections, Urologic Diseases, Wound Infection

NCT06170177 2023-12-14

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

Recruiting

4,000 enrolled

Genitourinary

Urinary Bladder Neoplasms, Disease Progression

NCT06115434 2023-11-03

Comparing Operative, Postoperative and Quality of Life of Patients After Salvage and Radical Cystectomy

Unknown

80 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT03912818 2023-09-11

Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer

Phase 2 Terminated

7 enrolled 9 charts

GenitourinarySarcoma

Bladder Adenocarcinoma

NCT04391790 2023-04-27

MOSAIC

Phase NA Unknown

300 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT03529890 2022-10-20

RACE IT

Phase 2 Unknown

33 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT02924480 2022-03-09

Lidocaine

Phase NA Completed

50 enrolled

Genitourinary

Invasive Bladder Cancer

NCT04570176 2022-02-16

Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System

Phase NA Completed

1 enrolled

EndocrineGenitourinary

Adrenal Gland Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Renal Cell

NCT02767921 2021-11-24

sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer

Phase 1 Terminated

2 enrolled

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT04900558 2021-05-25

Robotic Radical Cystectomy Outcomes

Recruiting

500 enrolled

Genitourinary

Urinary Bladder Neoplasms, Neoplasms, Recurrence

NCT03977831 2021-01-26

Study Comparing Open Radical Cystectomy With Robot-assisted Cystectomy in Patients With Bladder Cancer

Phase NA Completed

50 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT02861196 2020-12-17

Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer

Phase NA Completed

59 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT04610385 2020-10-30

Ileal Conduit Versus Cutaneous Ureterostomy After Radical Cystectomy

Unknown

40 enrolled

Genitourinary

Urinary Bladder Neoplasms, Patient Satisfaction

NCT04588168 2020-10-19

Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma

Phase NA Recruiting

100 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT04228198 2020-01-14

Protocol of the Italian Radical Cystectomy Registry

Unknown

1,000 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT02716896 2019-11-25

Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer

Phase NA Terminated

2 enrolled 8 charts

Genitourinary

Muscle Invasive Bladder Cancer

NCT02699853 2019-05-03

Robotic or Open Radical Cystectomy in Treating Patients With Bladder Cancer

Phase NA Terminated

1 enrolled

Genitourinary

Stage 0is Bladder Urothelial Carcinoma

NCT03238664 2018-01-02

Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder Tumors

Phase NA Withdrawn

Genitourinary

Carcinoma, Transitional Cell

NCT02944357 2017-11-17

Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery

Phase NA Withdrawn

Genitourinary

Infiltrating Bladder Urothelial Carcinoma

NCT00380029 2017-07-19

Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer

Phase 2 Completed

27 enrolled 12 charts

Genitourinary

Urinary Bladder Neoplasms

NCT00859339 2016-04-14

Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC

Phase 2 Terminated

9 enrolled 7 charts

Genitourinary

Transitional Cell Carcinoma of the Bladder

NCT01916109 2016-02-12

Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Phase 2 Terminated

4 enrolled 6 charts

Genitourinary

Cone Dystrophy 3, Urinary Bladder Neoplasms

NCT00585689 2015-11-30

Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer

Phase 2 Completed

29 enrolled 11 charts

Genitourinary

Urinary Bladder Neoplasms

Clinical Trials

TRIFECTA

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer

A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy

A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial

REDEMPTED

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

NEOBLAST

FUTURE

RAD-VACCINE

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy

Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma

Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

DIVON

Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt

CIMMIS

3 Tesla MRI in Patients With Bladder Cancer

AURA

ABATE

RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients

Infectious Complications After Cystectomy: A Prospective Observational Study

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

Comparing Operative, Postoperative and Quality of Life of Patients After Salvage and Radical Cystectomy

Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer

MOSAIC

RACE IT

Lidocaine

Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System

sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer

Robotic Radical Cystectomy Outcomes

Study Comparing Open Radical Cystectomy With Robot-assisted Cystectomy in Patients With Bladder Cancer

Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer

Ileal Conduit Versus Cutaneous Ureterostomy After Radical Cystectomy

Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma

Protocol of the Italian Radical Cystectomy Registry

Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer

Robotic or Open Radical Cystectomy in Treating Patients With Bladder Cancer

Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder Tumors

Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery

Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer

Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC

Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer